Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.

about

Targeted Therapies in Elderly Patients with Metastatic Colorectal Cancer: A Review of the Evidence.

Item

http://www.wikidata.org/entity/Q38961110

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeted Therapies in Elderly ...... cer: A Review of the Evidence.

@en

type

Item

label

Targeted Therapies in Elderly ...... cer: A Review of the Evidence.

@en

prefLabel

Targeted Therapies in Elderly ...... cer: A Review of the Evidence.

@en

P1476

Targeted Therapies in Elderly ...... ncer: A Review of the Evidence

@en

P2093

Amanda R Townsend

http://www.w3.org/2001/XMLSchema#string

Gonzalo Tapia Rico

http://www.w3.org/2001/XMLSchema#string

Vy Broadbridge

http://www.w3.org/2001/XMLSchema#string

P2860

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care

The emerging role of immunotherapy in colorectal cancer

Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others

Cancer statistics, 2016

P2888

s40266-017-0439-9

P304

173-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-017-0439-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timothy Price

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28197947

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer